Skip to main content

Table 1 Patient demographic characteristics by treatment group

From: A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2

 

rhBMP-2

map3

(n = 21)

(n = 20)

Segments treated

36

30

Male (n)

7

9

Female (n)

14

11

Age (years)

52.2 ± 10.3

53.9 ± 12.4

BMI

28.9 ± 5.5

28.7 ± 4.4

Obesity

7

5

Type II diabetes

2

4

Hypertensive

5

13

Current smokers

6

2

Former smokers

7

7